Trials / Completed
CompletedNCT02191215
Clinical and Therapeutic Evaluation of the Infection by HIV/AIDS
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 442 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The aim of the Post Marketing Study (PMS) is to evaluate the efficacy and safety profile of nevirapine in the management of the HIV/AIDS in an open environment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nevirapine (Viramune®) |
Timeline
- Start date
- 2003-06-01
- Primary completion
- 2004-05-01
- First posted
- 2014-07-16
- Last updated
- 2014-07-16
Source: ClinicalTrials.gov record NCT02191215. Inclusion in this directory is not an endorsement.